secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K
Filed at:   2023-06-08T23:59:59+00:00
Accession:  0001628908-23-000076
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Evolent Health shareholders approve all proposals at 2023 annual meeting
------------------------------------------------------------------------

- All nine director nominees elected with large majorities; no opponent received >8% against.
- Deloitte & Touche ratified as auditor for FY 2023: 105,998,310 for, 17,515 against.
- Advisory say-on-pay for 2022 NEO compensation approved: 98,899,814 for, 1,875,305 against.
- Amendment to 2015 Omnibus Incentive Compensation Plan approved: 96,632,166 for, 4,123,883 against.
- Meeting held June 8, 2023; broker non-votes of 5,271,272 on all director and compensation proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000162890823000076/0001628908-23-000076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000162890823000076/evh-20230608.htm
  HTML page:      https://secwatch.observer/filing/0001628908-23-000076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer